MedPath

TEGRETOL CR

TEGRETOL CR

Approved
DIN Number

00755583

Drug Class

Human

Market Date

Dec 31, 1988

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00755583
AIG Number0108674004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AF01 CARBAMAZEPINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

CARBAMAZEPINEActive
Strength: 400 MG
Monograph: CARBAMAZEPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.